Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis-Reference-Cited by-同舟云学术

Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis

Published:2020-07-14 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Di Tullio Francesca¹,Odorici Giulia¹²^ORCID,Lasagni Claudia¹,Capobianco Marco³^ORCID,Conti Andrea¹^ORCID,Mandel Victor Desmond¹⁴^ORCID

Affiliation:

1. Dermatology Unit, Surgical, Medical, and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy

2. Section of Dermatology and Infectious Diseases, Department of Medical Sciences University of Ferrara Ferrara Italy

3. Department of Neurology, Regional Multiple Sclerosis Center Azienda Ospedaliero‐Universitaria San Luigi Gonzaga Orbassano Italy

4. Dermatology Unit, Department of Clinical and Experimental Medicine University of Parma Parma Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13943

Reference15 articles.

1. A narrative review of psoriasis and multiple sclerosis: links and risks;Silfvast‐Kaiser AS;Psoriasis (Auckl),2019

2. Chronic kidney disease in psoriasis: a cohort study;Conti A;J Dtsch Dermatol Ges,2020

3. Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study

4. Demyelinating disease following anti‐TNFa treatment: a causal or coincidental association? Report of four cases and review of the literature;Andreadou E;Case Rep Neurol Med,2013

5. Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review;Multiple Sclerosis Journal;2024-02-22

2. Risk of multiple sclerosis in patients with psoriasis receiving anti‐IL‐17 agents: A case‐based review;The Journal of Dermatology;2024-02-12

3. Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis;Rheumatology;2022-11-28

4. Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review;American Journal of Clinical Dermatology;2021-04-16

5. Multiple drugs;Reactions Weekly;2021-02